Table 1 Comparison of LVEF, DC, PE, and BC6 between patients who survived (S) during the follow-up and those who died (ACM, AM, NAM).
From: Risk stratifiers for arrhythmic and non-arrhythmic mortality after acute myocardial infarction
LVEF [%] | DC | PE | BC6 | |
|---|---|---|---|---|
Survivors | 30.55 ± 7.28 | 4.69 ± 3.55 | 0.79 ± 2.27 | 1.04 ± 0.63 |
All-Cause Mortality | 26.52 ± 7.91 | 2.25 ± 4.41 | 1.81 ± 3.01 | 0.87 ± 0.62 |
p-value S vs ACM | <0.0001 | <0.0001 | 0.0031 | 0.0224 |
Non-Arrhythmic Mortality | 24.84 ± 8.61 | 2.68 ± 3.25 | 2.21 ± 3.71 | 1.06 ± 0.61 |
p-value S vs NAM | 0.0008 | 0.0019 | 0.0395 | 0.8371 |
Arrhythmic Mortality | 26.88 ± 7.53 | 1.53 ± 5.43 | 1.55 ± 2.71 | 0.76 ± 0.62 |
p-value S vs AM | 0.0033 | 0.0005 | 0.0782 | 0.0071 |
p-value NAM vs AM | 0.1873 | 0.2132 | 0.4566 | 0.0296 |